Vietnamese health authorities are sounding the alarm as pharmacies nationwide are increasingly being caught selling counterfeit drugs, unlicensed medications, and dietary supplements containing banned ...

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Esomeprazole (CAS 119141-88-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...

Esomeprazole oral capsule is a prescription drug that decreases the amount of acid the stomach makes. It can be used to treat GERD, esophagitis, and other conditions, and to prevent stomach ulcers ...

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (FDA) for esomeprazole magnesium delayed-release capsules USP, 20 mg (OTC), determined by ...

Glenmark Specialty SA of Glenmark Pharmaceutical has received final approval from the United States Food & Drug Administration (USFDA) for Esomeprazole Magnesium delayed-release capsules USP, 20 ...

The Esomeprazole market size is anticipated to grow from USD 1.91 Billion in 2023 to USD 3.22 Billion in 10 years. The market ought to witness a positive growth rate owing to growing cases ...

This study is looking at the long term benefits and risks of taking aspirin and esomeprazole to help prevent oesophageal cancer.

Granules India receives ANDA approval for Esomeprazole Magnesium Delayed-Release capsules Esomeprazole Magnesium capsules are indicated for short-term treatment of heartburn and other symptoms ...

Granules India receives US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules, a generic version of AstraZeneca's Nexium. The annual US market for the drug is $168M, and Granules now ...

Marksans Pharma Limited receives US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC), used to treat acid reflux, ulcers, and other stomach/esophagus issues. It ...